{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:59:10Z","timestamp":1788897550591,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82004321"],"award-info":[{"award-number":["82004321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074336"],"award-info":[{"award-number":["82074336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070633"],"award-info":[{"award-number":["82070633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["20XD1403700"],"award-info":[{"award-number":["20XD1403700"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Excessive inflammatory response is the primary cause of early death in patients with endotoxemia. Interleukin 22 (IL-22) has been shown to play critical roles in the modulation of infectious diseases, but its function in regulating immune responses during endotoxemia remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Lipopolysaccharide (LPS) was used to induce endotoxemia mouse model with or without a recombinant fusion protein containing human IL-22 (F-652). IL-6, TNF-\u03b1, IL-1\u03b2, and MCP-1 were measured by ELISA assays. The type of macrophage was assessed by flow cytometry. Real-time PCR was used to detect the expression of S100A9.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that F-652 injection significantly improved the survival rates and reduced pro-inflammatory cytokines (IL-6, TNF-a, IL-1\u03b2, MCP-1) in LPS-induced endotoxemia mice. However, the mice injected with F-652 had a higher number of infiltrated immune cells after LPS treatment, suggesting an impaired immune response. Flow cytometry analysis showed a higher number of F4\/80<jats:sup>+<\/jats:sup>Ly6G<jats:sup>hi<\/jats:sup>Ly6C<jats:sup>hi<\/jats:sup> cells that highly expressed M2-like macrophage markers (Ym1, Arg, CCL17) in the peritoneal cavity of the F-652-treated endotoxemia mice. Further investigation found that these suppressive M2 macrophages might be induced by F-652 since the F-652 treatment could increase S100A9 in vitro.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study suggests that IL-22 has a protective role against endotoxemia by inducing the development of immunosuppressive cells through S100A9.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12865-022-00511-6","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T11:03:12Z","timestamp":1663585392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Interleukin-22 protects from endotoxemia by inducing suppressive F4\/80+Ly6GhiLy6Chi cells population"],"prefix":"10.1186","volume":"23","author":[{"given":"Chang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhe","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"issue":"3","key":"511_CR1","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/CCM.0000000000004155","volume":"48","author":"J Xie","year":"2020","unstructured":"Xie J, Wang H, Kang Y, Zhou L, Liu Z, Qin B, et al. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey. Crit Care Med. 2020;48(3):e209\u201318.","journal-title":"Crit Care Med"},{"issue":"8","key":"511_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"2","key":"511_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1164\/rccm.202004-1201OC","volume":"203","author":"E Kyriazopoulou","year":"2021","unstructured":"Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, Panagaki A, Melachroinopoulos N, Drakou E, et al. Procalcitonin to reduce long-term infection-associated adverse events in sepsis. A randomized trial. Am J Respir Crit Care Med. 2021;203(2):202\u201310.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"511_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000505623","volume":"12","author":"H Herwald","year":"2020","unstructured":"Herwald H, Egesten A. Serious, severe, sepsis. J Innate Immun. 2020;12(2):129\u201330.","journal-title":"J Innate Immun"},{"key":"511_CR5","doi-asserted-by":"publisher","first-page":"107476","DOI":"10.1016\/j.pharmthera.2020.107476","volume":"208","author":"F Steinhagen","year":"2020","unstructured":"Steinhagen F, Schmidt SV, Schewe JC, Peukert K, Klinman DM, Bode C. Immunotherapy in sepsis\u2014brake or accelerate? Pharmacol Ther. 2020;208:107476.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"511_CR6","doi-asserted-by":"publisher","first-page":"e20192195","DOI":"10.1084\/jem.20192195","volume":"217","author":"M Keir","year":"2020","unstructured":"Keir M, Yi Y, Lu T, Ghilardi N. The role of IL-22 in intestinal health and disease. J Exp Med. 2020;217(3):e20192195.","journal-title":"J Exp Med"},{"issue":"4","key":"511_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","volume":"50","author":"W Ouyang","year":"2019","unstructured":"Ouyang W, O\u2019Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50(4):871\u201391.","journal-title":"Immunity"},{"key":"511_CR8","doi-asserted-by":"crossref","unstructured":"Leyva-Castillo JM, Yoon J, Geha RS. IL-22 promotes allergic airway inflammation in epicutaneously sensitized mice. J Allergy Clin Immunol. 2019;143(2):619\u201330e7.","DOI":"10.1016\/j.jaci.2018.05.032"},{"issue":"28","key":"511_CR9","doi-asserted-by":"publisher","first-page":"eaar7754","DOI":"10.1126\/sciimmunol.aar7754","volume":"3","author":"T Fabre","year":"2018","unstructured":"Fabre T, Molina MF, Soucy G, Goulet JP, Willems B, Villeneuve JP, et al. Type 3 cytokines IL-17A and IL-22 drive TGF-beta-dependent liver fibrosis. Sci Immunol. 2018;3(28):eaar7754.","journal-title":"Sci Immunol"},{"issue":"1","key":"511_CR10","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","volume":"11","author":"W Yang","year":"2020","unstructured":"Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11(1):4457.","journal-title":"Nat Commun"},{"key":"511_CR11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3389\/fimmu.2020.01315","volume":"11","author":"HX Wei","year":"2020","unstructured":"Wei HX, Wang B, Li B. IL-10 and IL-22 in mucosal immunity: driving protection and pathology. Front Immunol. 2020;11:1315.","journal-title":"Front Immunol"},{"issue":"1","key":"511_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12929-019-0539-4","volume":"26","author":"FC Yang","year":"2019","unstructured":"Yang FC, Chiu PY, Chen Y, Mak TW, Chen NJ. TREM-1-dependent M1 macrophage polarization restores intestinal epithelium damaged by DSS-induced colitis by activating IL-22-producing innate lymphoid cells. J Biomed Sci. 2019;26(1):46.","journal-title":"J Biomed Sci"},{"issue":"2","key":"511_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/hep.31031","volume":"72","author":"S Hwang","year":"2020","unstructured":"Hwang S, He Y, Xiang X, Seo W, Kim SJ, Ma J, et al. Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets. Hepatology. 2020;72(2):412\u201329.","journal-title":"Hepatology"},{"issue":"6","key":"511_CR14","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","volume":"174","author":"K Boniface","year":"2005","unstructured":"Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 2005;174(6):3695\u2013702.","journal-title":"J Immunol"},{"issue":"13","key":"511_CR15","doi-asserted-by":"publisher","first-page":"108571","DOI":"10.1016\/j.celrep.2020.108571","volume":"33","author":"T Kwak","year":"2020","unstructured":"Kwak T, Wang F, Deng H, Condamine T, Kumar V, Perego M, et al. Distinct populations of immune-suppressive macrophages differentiate from monocytic myeloid-derived suppressor cells in cancer. Cell Rep. 2020;33(13):108571.","journal-title":"Cell Rep"},{"key":"511_CR16","doi-asserted-by":"publisher","first-page":"107791","DOI":"10.1016\/j.intimp.2021.107791","volume":"96","author":"X Chen","year":"2021","unstructured":"Chen X, Liu Y, Gao Y, Shou S, Chai Y. The roles of macrophage polarization in the host immune response to sepsis. Int Immunopharmacol. 2021;96:107791.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"511_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41423-018-0029-8","volume":"16","author":"KY Tang","year":"2019","unstructured":"Tang KY, Lickliter J, Huang ZH, Xian ZS, Chen HY, Huang C, et al. Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects. Cell Mol Immunol. 2019;16(5):473\u201382.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"511_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/hep.31046","volume":"72","author":"JP Arab","year":"2020","unstructured":"Arab JP, Sehrawat TS, Simonetto DA, Verma VK, Feng D, Tang T, et al. An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis. Hepatology. 2020;72(2):441\u201353.","journal-title":"Hepatology"},{"issue":"11","key":"511_CR19","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41419-020-03176-4","volume":"11","author":"L Shao","year":"2020","unstructured":"Shao L, Xiong X, Zhang Y, Miao H, Ren Y, Tang X, et al. IL-22 ameliorates LPS-induced acute liver injury by autophagy activation through ATF4-ATG7 signaling. Cell Death Dis. 2020;11(11):970.","journal-title":"Cell Death Dis"},{"issue":"4","key":"511_CR20","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1128\/IAI.01564-06","volume":"75","author":"GF Weber","year":"2007","unstructured":"Weber GF, Schlautkotter S, Kaiser-Moore S, Altmayr F, Holzmann B, Weighardt H. Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis. Infect Immun. 2007;75(4):1690\u20137.","journal-title":"Infect Immun"},{"issue":"8","key":"511_CR21","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1172\/JCI75005","volume":"127","author":"K Rahman","year":"2017","unstructured":"Rahman K, Vengrenyuk Y, Ramsey SA, Vila NR, Girgis NM, Liu J, et al. Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression. J Clin Invest. 2017;127(8):2904\u201315.","journal-title":"J Clin Invest"},{"issue":"9","key":"511_CR22","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.4049\/jimmunol.0904091","volume":"185","author":"SC Liang","year":"2010","unstructured":"Liang SC, Nickerson-Nutter C, Pittman DD, Carrier Y, Goodwin DG, Shields KM, et al. IL-22 induces an acute-phase response. J Immunol. 2010;185(9):5531\u20138.","journal-title":"J Immunol"},{"issue":"10","key":"511_CR23","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.4049\/jimmunol.1402164","volume":"194","author":"L Sun","year":"2015","unstructured":"Sun L, Zhou H, Zhu Z, Yan Q, Wang L, Liang Q, et al. Ex vivo and in vitro effect of serum amyloid a in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophils. J Immunol. 2015;194(10):4891\u2013900.","journal-title":"J Immunol"},{"issue":"12","key":"511_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nri3766","volume":"14","author":"S Rutz","year":"2014","unstructured":"Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines\u2013from host defence to tissue homeostasis. Nat Rev Immunol. 2014;14(12):783\u201395.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"511_CR25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","volume":"72","author":"X Xiang","year":"2020","unstructured":"Xiang X, Feng D, Hwang S, Ren T, Wang X, Trojnar E, et al. Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice. J Hepatol. 2020;72(4):736\u201345.","journal-title":"J Hepatol"},{"issue":"5","key":"511_CR26","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.4049\/jimmunol.1600528","volume":"197","author":"G Trevejo-Nunez","year":"2016","unstructured":"Trevejo-Nunez G, Elsegeiny W, Conboy P, Chen K, Kolls JK. Critical role of IL-22\/IL22-RA1 signaling in pneumococcal pneumonia. J Immunol. 2016;197(5):1877\u201383.","journal-title":"J Immunol"},{"key":"511_CR27","doi-asserted-by":"publisher","first-page":"101636","DOI":"10.1016\/j.redox.2020.101636","volume":"36","author":"J Ye","year":"2020","unstructured":"Ye J, Wang Y, Xu Y, Wang Z, Liu L, Wang M, et al. Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK\/macrophage\/Fizz3 axis in mice. Redox Biol. 2020;36:101636.","journal-title":"Redox Biol"},{"issue":"5","key":"511_CR28","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1111\/jcmm.14967","volume":"24","author":"L Shi","year":"2020","unstructured":"Shi L, Ji Q, Liu L, Shi Y, Lu Z, Ye J, et al. IL-22 produced by Th22 cells aggravates atherosclerosis development in ApoE(-\/-) mice by enhancing DC-induced Th17 cell proliferation. J Cell Mol Med. 2020;24(5):3064\u201378.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"511_CR29","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","volume":"68","author":"T Hendrikx","year":"2019","unstructured":"Hendrikx T, Duan Y, Wang Y, Oh JH, Alexander LM, Huang W, et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut. 2019;68(8):1504\u201315.","journal-title":"Gut"},{"issue":"12","key":"511_CR30","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/cells8121587","volume":"8","author":"EY Kim","year":"2019","unstructured":"Kim EY, Noh HM, Choi B, Park JE, Kim JE, Jang Y, et al. Interleukin-22 induces the infiltration of visceral fat tissue by a discrete subset of Duffy antigen receptor for chemokine-positive M2-like macrophages in response to a high fat diet. Cells. 2019;8(12):1587.","journal-title":"Cells"},{"key":"511_CR31","doi-asserted-by":"publisher","first-page":"118677","DOI":"10.1016\/j.lfs.2020.118677","volume":"264","author":"SB Su","year":"2021","unstructured":"Su SB, Qin SY, Xian XL, Huang FF, Huang QL, ZhangDi HJ, et al. Interleukin-22 regulating Kupffer cell polarization through STAT3\/Erk\/Akt crosstalk pathways to extenuate liver fibrosis. Life Sci. 2021;264:118677.","journal-title":"Life Sci"},{"issue":"4","key":"511_CR32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/icb.2016.107","volume":"95","author":"SA Budda","year":"2017","unstructured":"Budda SA, Bhattarai K, Alexander JL, Zenewicz LA. Hypoxic modulation of hepatocyte responses to the cytokine interleukin-22. Immunol Cell Biol. 2017;95(4):380\u20137.","journal-title":"Immunol Cell Biol"},{"key":"511_CR33","doi-asserted-by":"publisher","first-page":"658681","DOI":"10.3389\/fimmu.2021.658681","volume":"12","author":"L Hu","year":"2021","unstructured":"Hu L, Liu Y, Kong X, Wu R, Peng Q, Zhang Y, et al. Fusobacterium nucleatum facilitates M2 macrophage polarization and colorectal carcinoma progression by activating TLR4\/NF-kappaB\/S100A9 cascade. Front Immunol. 2021;12:658681.","journal-title":"Front Immunol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-022-00511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-022-00511-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-022-00511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T11:06:38Z","timestamp":1663585598000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-022-00511-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1186\/s12865-022-00511-6","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The care and use of the mice were all approved by the Ethics committee of the Shanghai University of Chinese Traditional Medicine. All animal experiments were proceeded following the guidelines of the Shanghai University of Chinese Traditional Medicine Regulation for Administration of Laboratory Animals and were performed in compliance with the ARRIVE guidelines ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author Juhong Liu and Zhihua Huang were employed by the company Evive Biotechnology (Shanghai) Ltd, China. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}